Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accessed, advice, al, alopecia, anytime, arbitration, Australia, Azimuth, Biomedical, BioResearch, bleeding, cardiac, casualty, CI, cited, Commerce, CompanyRonald, complementary, composition, Condensed, Conference, Confidence, CRC, CRPC, devote, disaggregated, disagreement, disclaimer, dismissed, docataxel, Doctor, entertainment, Ernst, explanatory, Extropy, febrile, female, gary, Genetic, Guelph, gynecologic, hair, Harvard, hazard, headquarter, hereof, HR, hypersensitivity, imbalance, infusion, Interactive, Interval, junior, lab, labor, landlord, lengthy, liposomal, literature, lost, lt, magnitude, matter, multicenter, narrow, NEJM, nephrotoxicity, Nonclinical, Ontario, ototoxicity, paragraph, path, payer, pediatric, pegylated, peritoneal, Perry, Pharsight, PLD, preliminary, premature, prepaid, proposition, prudent, purpose, radiologic, ranking, rata, rationally, reclassified, reconciliation, rectum, reissue, rejection, repair, reproductive, Retention, Russia, save, seldom, sinking, specialty, statistical, statistically, stepped, strain, sublease, subleased, subleasing, synergistic, SyStemix, Tannock, taxane, transient, undesignated, unpublished, unusual, Veracyte, volume, worth, Young
Removed:
accelerate, accept, accredited, accrual, adjacent, adjustable, APB, applying, appraisal, arising, arm, ascribed, assumed, attached, authority, BCC, began, binomial, biochemistry, biology, building, buy, cancelled, career, close, commissioned, comparator, computer, Concurrent, confined, conventional, convertibility, created, decommissioning, destroy, distinction, drawn, earned, embark, employed, Employer, ensuring, exhibiting, expensing, expired, feature, fellowship, FIN, finalization, fractional, furniture, gave, Harrison, Hospital, hundred, implementation, ineffective, inhibitor, innovative, IRS, Journal, kill, kinase, lieu, McAllen, Missouri, molecule, moved, MURR, negotiate, nominated, Occasionally, occupied, parking, Pharmacia, plant, played, Polytechnic, presenting, prime, promissory, protein, radiopharmaceutical, rationale, Reactor, refected, reissuable, relocate, relocation, Rensselaer, residency, restructured, Scientist, select, sensitive, situation, size, smoking, staging, Street, subset, SUGEN, suggested, sutent, technique, topotecan, toxic, traditional, TSRI, unpaid, unwilling, utility, varied, viable, Wall, weighting
Filing tables
Filing exhibits
Related press release
PARD similar filings
Filing view
External links
Exhibit 23.1
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
- •
- Registration Statements (Form S-3 Nos. 333-159253, 333-134480 and 333-123672) of Poniard Pharmaceuticals, Inc.; and
- •
- Registration Statements (Form S-8 Nos. 333-143965, 333-135861, 333-126209, 333-115729, and 333-89476) pertaining to the Amended and Restated 2004 Incentive Compensation Plan and Registration Statements (Form S-8 Nos. 333-41764, 333-32583, 33-43860, 33-46317 and 33-87108) pertaining to the Restated 1994 Stock Option Plan of Poniard Pharmaceuticals, Inc.
of our reports dated March 16, 2010, with respect to the consolidated financial statements of Poniard Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Poniard Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2009.
/s/ Ernst & Young LLP
Palo Alto, California
March 16, 2010